placeUnited Kingdom
Contact & Support
Medtronic / Covidien Products / Vessel Sealing / LigaSure™ Robotic-Assisted Surgery (RAS) Maryland Jaw Vessel Sealer-Divider

Overview

  

Get ready for a new era in robotic-assisted surgery (RAS).

The LigaSure™ RAS Maryland jaw device is the first robotically driven LigaSure™ instrument, combining the reliable vessel sealing of the ValleyLab™ FT10 generator with the versatility of the Hugo™ RAS system.1,2

Reliable vessel sealing for robotic procedures†,3
  • Seals vessels up to 7 mm in diameter‡,4,5
  • Same LigaSure™ burst pressure performance standard of 360 mmHg (3x systolic blood pressure)‡,4,5
  • Provides effective ligation and division of vessels, thick tissue (tissue bundles), and lymphatics1,2,6
Multifunctional design for improved procedural efficiency§,◊,3
  • Effective cold cutting§,3
  • Secure, atraumatic grasping†,3
  • Fewer interruptions§,¶,3
  • Curved jaws allow for improved access over straight jaws†,3

Advancing RAS starts with trust — and LigaSure™ technology has earned the trust of surgeons in more than 35 million procedures. Let’s redefine robotics together with the LigaSure™ RAS Maryland jaw device.

FEATURES

A proven choice in open and lap, available now for robotic surgery.

See how the LigaSure™ RAS Maryland jaw device pairs with the Hugo™ RAS system to give you confidence in every seal.

Learn more about Hugo™ RAS system

Resources

  • † 16 of 16 surgeons surveyed after use agreed.

  • ‡ Bench tissue and animal model may not be indicative of clinical tissue performance but is a controllable substitute acceptable to regulatory bodies.

  • § 15 of 16 surgeons surveyed after use agreed.

  • ◊ Compared to procedures without a vessel sealer. 

  • ¶ Based on internal sales data from FY01–FY23. November 2023.

  • 1. LigaSure™ RAS Maryland indications for use. p5. 2024.

  • 2. Based on internal test report RE00476319, Verification acute. Table 1. October 19, 2019.

  • 3. Based on internal test report RE00540481, LigaSure™ RAS Maryland jaw sealer/divider surgeon validation marketing report. Based on porcine model. April 26–May 3, 2024.

  • 4. Based on internal test report RE00476260, Marystein bench top tissue study. Table 1. August 15, 2024.

  • 5. Based on internal test report RE00476323, LigaSure™ RAS Maryland jaw vessel sealer/divider in chronic hemostatis porcine study. December 9, 2023.

  • 6. Based on internal test report RE00476346, LigaSure™ RAS Maryland jaw vessel sealer/divider in a lymphatic burst study porcine model. Table 1. August 11, 2024.

Corporate Resources
Medical Surgical Portfolio
Additional Resources
Contact Us
Medtronic Limited

Building 9, Croxley Park

Hatters Lane

Watford, WD18 8WW

United Kingdom

©2025 Medtronic
2025-06